Intensive diabetes treatment and overtreatment can compromise health among clinically complex consumers. These consumers often experience more hospitalizations and emergency department visits for hypoglycemia (low blood sugar), related to this intensive treatment or overtreatment. Intensive treatment was defined in the study as the use of any glucose-lowering medications with HbA1c levels of 5.6% or less, or two or more medications with HbA1c levels between 5.7% and 6.4%. Clinically complex consumers are those who meet all of the following conditions: Are age 75 or older Have two or more limitations on daily living . . .